<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39427188</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-2994</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>Antimicrobial resistance and infection control</Title><ISOAbbreviation>Antimicrob Resist Infect Control</ISOAbbreviation></Journal><ArticleTitle>Outbreak with OXA-23-producing Acinetobacter baumannii in a COVID-19 ICU cohort: unraveling routes of transmission.</ArticleTitle><Pagination><StartPage>127</StartPage><MedlinePgn>127</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">127</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13756-024-01485-3</ELocationID><Abstract><AbstractText>An outbreak of OXA-23-producing carbapenem-resistant Acinetobacter baumannii amongst ICU-patients with COVID-19 likely occurred by transmission through inanimate surfaces, potentially facilitated by a contaminated positioning pillow shared between patients. Subsequent rapid spread may have been caused by exposure to respiratory secretions contaminating healthcare worker's gloves and gowns during prone positioning.</AbstractText><CopyrightInformation>Â© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zingg</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Rotz</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portmann</LastName><ForeName>Aurore</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egli</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seth-Smith</LastName><ForeName>Helena M B</ForeName><Initials>HMB</Initials><AffiliationInfo><Affiliation>Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlaepfer</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory Medicine, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldenberger</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassetti</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsch</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pargger</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuehl</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tschudin-Sutter</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland. sarah.tschudin@usb.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Resist Infect Control</MedlineTA><NlmUniqueID>101585411</NlmUniqueID><ISSNLinking>2047-2994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.5.2.6</RegistryNumber><NameOfSubstance UI="D001618">beta-Lactamases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015780">Carbapenems</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040981" MajorTopicYN="Y">Acinetobacter baumannii</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000151" MajorTopicYN="Y">Acinetobacter Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001618" MajorTopicYN="Y">beta-Lactamases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="Y">Cross Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015780" MajorTopicYN="N">Carbapenems</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>S. Tschudin-Sutter serves as editor of the journal Antimicrobial Resistance and Infection Control.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39427188</ArticleId><ArticleId IdType="pmc">PMC11491009</ArticleId><ArticleId IdType="doi">10.1186/s13756-024-01485-3</ArticleId><ArticleId IdType="pii">10.1186/s13756-024-01485-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC, COVID-19:. U.S. Impact on Antimicrobial Resistance, Special Report 2022. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2022. https://www.cdc.gov/drugresistance/covid19.html.</Citation></Reference><Reference><Citation>Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629â655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19. Erratum in: Lancet. 2022;400(10358):1102. PMID: 35065702; PMCID: PMC8841637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841637</ArticleId><ArticleId IdType="pubmed">35065702</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins PG, Prior K, Harmsen D, Seifert H. Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii. PLoS ONE. 2017;12(6):e0179228. 10.1371/journal.pone.0179228. PMID: 28594944; PMCID: PMC5464626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464626</ArticleId><ArticleId IdType="pubmed">28594944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595. 10.1371/journal.pcbi.1005595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5481147</ArticleId><ArticleId IdType="pubmed">28594827</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman T, Fedorowsky R, Yerushalmi R, Lellouche J, Nutman A. An outbreak of carbapenem-resistant Acinetobacter baumannii in a COVID-19 dedicated hospital. Infect Prev Pract. 2021;3(1):100113. 10.1016/j.infpip.2021.100113. Epub 2021 Jan 9. PMID: 34316574; PMCID: PMC7794049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794049</ArticleId><ArticleId IdType="pubmed">34316574</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A, Gavaruzzi F, Ceccarelli G, Borrazzo C, Oliva A, Alessandri F, Magnanimi E, Pugliese F, Venditti M. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022;50(1):83â92. 10.1007/s15010-021-01643-4. Epub 2021 Jun 27. PMID: 34176088; PMCID: PMC8236000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236000</ArticleId><ArticleId IdType="pubmed">34176088</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinohara D, Dos Santos Saalfeld S, Martinez H, Altafini D, Costa B, Fedrigo N, Tognim M. Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavirus disease 2019 (COVID-19)âspecific intensive care unit. Infect Control Hosp Epidemiol. 2022;43(6):815â7. 10.1017/ice.2021.98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7985906</ArticleId><ArticleId IdType="pubmed">33685542</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez S, Innes GK, Walters MS, Mehr J, Arias J, Greeley R, Chew D. Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii infection and colonization in an Acute Care Hospital during a Surge in COVID-19 admissions - New Jersey, February-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(48):1827â31. 10.15585/mmwr.mm6948e1. PMID: 33270611; PMCID: PMC7714028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7714028</ArticleId><ArticleId IdType="pubmed">33270611</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascale R, Bussini L, Gaibani P, Bovo F, Fornaro G, Lombardo D, Giannella M. Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: a multicenter before-and-after cross-sectional study. Infect Control Hosp Epidemiol. 2022;43(4):461â6. 10.1017/ice.2021.144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365044</ArticleId><ArticleId IdType="pubmed">33858547</ArticleId></ArticleIdList></Reference><Reference><Citation>Green, et al. Bacterial hydrophilins promote pathogen dissication tolerance. Cell Host Microbe. 2022. 10.1016/j.chom.2022.03.19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9283220</ArticleId><ArticleId IdType="pubmed">35413266</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoma R, Seneghini M, Seiffert SN, et al. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida Auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob Resist Infect Control. 2022;11:12. 10.1186/s13756-022-01052-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8777447</ArticleId><ArticleId IdType="pubmed">35063032</ArticleId></ArticleIdList></Reference><Reference><Citation>Segala FV, Bavaro DF, Di Gennaro F, Salvati F, Marotta C, Saracino A, Murri R, Fantoni M. Impact of SARS-CoV-2 epidemic on Antimicrobial Resistance: A literature review. Viruses. 2021;13(11):2110. 10.3390/v13112110. PMID: 34834917; PMCID: PMC8624326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8624326</ArticleId><ArticleId IdType="pubmed">34834917</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutman A, Levi GD, Keren-Paz A, et al. Active surveillance for carbapenem-resistant Acinetobacter baumannii (CRAB) carriage. Microbiol Spectr. 2023;11(6):e0314623. 10.1128/spectrum.03146-23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715071</ArticleId><ArticleId IdType="pubmed">37943045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>